Related Experiment Video
Updated: Aug 15, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors
M N Kitaeva1, L Grogan, J P Williams
1Genetics Department, National Cancer Institute, Bethesda, Maryland 20889-5101, USA.
Abstract:
Beta-catenin has been identified as an oncogene in colon cancer and melanoma. Phosphorylation of sites in exon 3 of beta-catenin leads to degradation of this protein. These sites are primary targets for activating mutations. The frequency with which oncogenic mutations at these sites are found in colorectal cancer is unknown, as is the frequency of their occurrence in other malignancies. We analyzed 92 colorectal cancers (CRCs) and 57 cancer cell lines (representing a diversity of tumor types) to determine the frequency of activating mutations in this gene. Mutations in exon 3 of beta-catenin were found in 2 of 92 CRCs and in the colorectal cancer cell line HCT 116. Both tumors with beta-catenin mutations exhibited widespread microsatellite instability, which is indicative of a replication error phenotype, a phenotype known to be present in HCT 116. This suggests that mutations in beta-catenin are infrequent in CRC and miscellaneous cancer cell lines and may occur in association with a replication error phenotype.
Insights
Activating mutations in beta-catenin are rare in colorectal cancer (CRC) and other cancers. These rare beta-catenin mutations were associated with microsatellite instability, a DNA replication error phenotype.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Beta-catenin is an oncogene implicated in colon cancer and melanoma.
- Activating mutations in beta-catenin, often targeting exon 3 phosphorylation sites, lead to protein stabilization and oncogenic activity.
- The frequency of these specific mutations in colorectal cancer (CRC) and other malignancies is largely undetermined.
Purpose of the Study:
- To investigate the frequency of activating mutations in exon 3 of the beta-catenin gene in colorectal cancers (CRCs) and various cancer cell lines.
- To explore the potential association of these mutations with specific tumor characteristics, such as microsatellite instability.
Main Methods:
- Analysis of 92 colorectal cancer (CRC) samples.
- Analysis of 57 cancer cell lines representing diverse tumor types.
- Mutation screening focused on exon 3 of the beta-catenin gene.
Main Results:
- Activating mutations in beta-catenin exon 3 were identified in 2 out of 92 CRCs.
- One colorectal cancer cell line (HCT 116) also harbored a beta-catenin mutation.
- Both CRCs with beta-catenin mutations displayed widespread microsatellite instability (MSI).
Conclusions:
- Activating mutations in beta-catenin appear to be infrequent in both CRC and a panel of miscellaneous cancer cell lines.
- The occurrence of beta-catenin mutations in CRC may be associated with a replication error phenotype, characterized by microsatellite instability.
Related Concept Videos
Mismatch Repair
Genome Copying Errors
Cancers Originate from Somatic Mutations in a Single Cell
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Cancers Originate from Somatic Mutations in a Single Cell

